Agile Therapeutics - Stock Split History | AGRX
Stock split history for Agile Therapeutics since 2019. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
|Agile Therapeutics Annual Stock Splits
|Agile Therapeutics Quarterly Stock Splits
||Medical - Generic Drugs
Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. It is focused on the development and commercialization of new prescription contraceptive products. The Company's lead product candidate is Twirla (TM), also known as AG200-15, a once-weekly prescription contraceptive patch currently in Phase 3 clinical development. Agile Therapeutics, Inc. is headquartered in Princeton, New Jersey.